S&P 500   4,207.27
DOW   33,336.67
QQQ   324.08
Find and Profitably Trade Stocks at 52-Week Lows
27 U.S. Cities Where Stocks Yield 26% a Year (Ad)pixel
Why Invest in High-Yield Dividend Stocks?
The 2 Dow Stocks with Decade-Long Win Streaks on the Line
3 Stable Growth Stocks for Bumpy Times
27 U.S. Cities Where Stocks Yield 26% a Year (Ad)pixel
Disney (NYSE: DIS) Shares Just Gave Investors A Massive Signal
Solar Stocks Shine Brightly After Passage Of Clean Energy Bill
Large And Small Oil-And-Gas Stocks See Post-Earnings Bounce
Our #1 Small-Cap Stock for [MONTH] (Ad)pixel
S&P 500   4,207.27
DOW   33,336.67
QQQ   324.08
Find and Profitably Trade Stocks at 52-Week Lows
27 U.S. Cities Where Stocks Yield 26% a Year (Ad)pixel
Why Invest in High-Yield Dividend Stocks?
The 2 Dow Stocks with Decade-Long Win Streaks on the Line
3 Stable Growth Stocks for Bumpy Times
27 U.S. Cities Where Stocks Yield 26% a Year (Ad)pixel
Disney (NYSE: DIS) Shares Just Gave Investors A Massive Signal
Solar Stocks Shine Brightly After Passage Of Clean Energy Bill
Large And Small Oil-And-Gas Stocks See Post-Earnings Bounce
Our #1 Small-Cap Stock for [MONTH] (Ad)pixel
S&P 500   4,207.27
DOW   33,336.67
QQQ   324.08
Find and Profitably Trade Stocks at 52-Week Lows
27 U.S. Cities Where Stocks Yield 26% a Year (Ad)pixel
Why Invest in High-Yield Dividend Stocks?
The 2 Dow Stocks with Decade-Long Win Streaks on the Line
3 Stable Growth Stocks for Bumpy Times
27 U.S. Cities Where Stocks Yield 26% a Year (Ad)pixel
Disney (NYSE: DIS) Shares Just Gave Investors A Massive Signal
Solar Stocks Shine Brightly After Passage Of Clean Energy Bill
Large And Small Oil-And-Gas Stocks See Post-Earnings Bounce
Our #1 Small-Cap Stock for [MONTH] (Ad)pixel
S&P 500   4,207.27
DOW   33,336.67
QQQ   324.08
Find and Profitably Trade Stocks at 52-Week Lows
27 U.S. Cities Where Stocks Yield 26% a Year (Ad)pixel
Why Invest in High-Yield Dividend Stocks?
The 2 Dow Stocks with Decade-Long Win Streaks on the Line
3 Stable Growth Stocks for Bumpy Times
27 U.S. Cities Where Stocks Yield 26% a Year (Ad)pixel
Disney (NYSE: DIS) Shares Just Gave Investors A Massive Signal
Solar Stocks Shine Brightly After Passage Of Clean Energy Bill
Large And Small Oil-And-Gas Stocks See Post-Earnings Bounce
Our #1 Small-Cap Stock for [MONTH] (Ad)pixel
NASDAQ:PCVX

Vaxcyte - PCVX Insider Trading & Ownership

$25.36
-1.02 (-3.87%)
(As of 08/11/2022 12:00 AM ET)
Add
Compare
Today's Range
$25.00
$26.61
50-Day Range
$17.68
$26.38
52-Week Range
$16.78
$27.44
Volume
233,681 shs
Average Volume
333,535 shs
Market Capitalization
$1.48 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$52.00

Vaxcyte (NASDAQ:PCVX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
13.70%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
6
Amount Of
Insider Selling
(Last 12 Months)
$6.33 M

PCVX Insider Buying and Selling by Quarter

Get PCVX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Vaxcyte stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.


Vaxcyte Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/4/2022Jeff FairmanVPSell10,000$25.50$255,000.00311,227  
7/27/2022Paul SauerSVPSell3,000$25.00$75,000.0017,687  
7/26/2022Grant PickeringCEOSell10,000$23.27$232,700.00167,830  
7/20/2022Paul SauerSVPSell3,000$25.00$75,000.0020,687  
7/18/2022Andrew GuggenhimeCFOSell3,100$24.53$76,043.0042,187  
7/15/2022Grant PickeringCEOSell11,000$24.47$269,170.00683,456  
7/8/2022Andrew GuggenhimeCFOSell3,100$24.00$74,400.0042,187  
7/1/2022Jim WassilCOOSell2,800$22.00$61,600.0044,506  
6/28/2022Grant PickeringCEOSell10,000$21.00$210,000.00345,660  
6/23/2022Grant PickeringCEOSell3,541$21.01$74,396.41695,203  
6/21/2022Grant PickeringCEOSell5,451$21.05$114,743.55700,005  
5/23/2022Paul SauerSVPSell3,000$26.22$78,660.0023,687  
5/20/2022Jeff FairmanVPSell4,112$25.50$104,856.00321,227  
5/18/2022Andrew GuggenhimeCFOSell3,100$24.44$75,764.0042,187  
5/16/2022Grant PickeringCEOSell11,000$23.91$263,010.00703,894  
5/5/2022Jeff FairmanVPSell888$25.80$22,910.40325,339  
4/22/2022Paul SauerSVPSell3,000$25.00$75,000.0025,125  
4/18/2022Andrew GuggenhimeCFOSell3,100$24.05$74,555.0040,625  
4/18/2022Grant PickeringCEOSell11,000$23.98$263,780.00703,894  
4/18/2022Jim WassilCOOSell2,800$23.98$67,144.0042,944  
4/5/2022Jeff FairmanVPSell5,000$25.59$127,950.0016,629  
3/22/2022Paul SauerSVPSell3,000$25.00$75,000.00  
3/21/2022Grant PickeringCEOSell14,288$24.94$356,342.72  
3/11/2022Jeff FairmanVPSell10,000$25.50$255,000.00  
3/10/2022Paul SauerSVPSell6,000$25.00$150,000.00  
2/24/2022Jim WassilCOOSell10,000$22.00$220,000.00  
12/29/2021Paul SauerSVPSell6,000$25.00$150,000.00  
12/27/2021Jeff FairmanVPSell4,750$23.60$112,100.00  
12/23/2021Andrew GuggenhimeCFOSell3,100$24.00$74,400.00  
12/16/2021Jeff FairmanVPSell4,619$22.50$103,927.50  
12/9/2021Jeff FairmanVPSell131$22.50$2,947.50  
11/19/2021Grant PickeringCEOSell15,000$23.45$351,750.00  
11/18/2021Andrew GuggenhimeCFOSell3,100$24.53$76,043.00  
10/26/2021Jeff FairmanVPSell4,750$22.69$107,777.50  
10/20/2021Grant PickeringCEOSell15,000$22.58$338,700.00  
9/27/2021Jeff FairmanVPSell4,750$26.17$124,307.50  
9/22/2021Paul SauerSVPSell5,307$25.20$133,736.40  
9/21/2021Grant PickeringCEOSell10,807$25.22$272,552.54  
8/26/2021Jeff FairmanVPSell4,750$25.38$120,555.009,894  
8/23/2021Grant PickeringCEOSell13,669$22.73$310,696.37593,923  
8/16/2021Jane Wright-MitchellGeneral CounselSell2,500$26.00$65,000.00  
8/12/2021Jane Wright-MitchellGeneral CounselSell10,000$26.00$260,000.00  
7/26/2021Jeff FairmanVPSell4,750$22.70$107,825.009,894  
7/20/2021Grant PickeringCEOSell15,000$22.85$342,750.00595,254  
6/28/2021Jeff FairmanVPSell4,750$24.37$115,757.509,894  
6/24/2021Grant PickeringCEOSell13,863$23.09$320,096.67594,117  
6/21/2021Grant PickeringCEOSell1,063$22.05$23,439.15581,317  
6/7/2021Jeff FairmanVPSell9,500$22.50$213,750.00  
6/4/2021Grant PickeringCEOSell8,093$22.14$179,179.02587,259  
5/27/2021Grant PickeringCEOSell12,246$22.10$270,636.60  
3/26/2021Jeff FairmanVPSell4,750$23.88$113,430.006,158  
3/19/2021Grant PickeringCEOSell15,000$25.77$386,550.00593,691  
2/26/2021Jeff FairmanVPSell4,750$23.93$113,667.506,158  
2/11/2021Paul SauerSVPSell2,500$26.65$66,625.0080,399  
2/10/2021Robert Lorne HopfnerDirectorSell78,158$26.53$2,073,531.74  
2/8/2021Robert Lorne HopfnerDirectorSell79,796$25.79$2,057,938.84  
2/2/2021Robert Lorne HopfnerDirectorSell14,234$25.13$357,700.42  
1/27/2021Robert Lorne HopfnerDirectorSell2,140$25.30$54,142.00  
1/26/2021Jeff FairmanVPSell4,750$25.27$120,032.506,158  
1/25/2021Robert Lorne HopfnerDirectorSell34,972$25.81$902,627.32  
1/21/2021Robert Lorne HopfnerDirectorSell100$25.11$2,511.00  
1/20/2021Jim WassilCOOSell3,000$25.50$76,500.00  
1/19/2021Grant PickeringCEOSell15,000$25.10$376,500.00593,691  
1/19/2021Robert Lorne HopfnerDirectorSell49,516$25.62$1,268,599.92  
1/15/2021Jane Wright-MitchellGeneral CounselSell2,500$26.00$65,000.00  
1/15/2021Robert Lorne HopfnerDirectorSell26,677$25.78$687,733.06  
1/13/2021Robert Lorne HopfnerDirectorSell29,110$25.95$755,404.50  
1/11/2021Paul SauerSVPSell2,500$26.21$65,525.00  
1/11/2021Robert Lorne HopfnerDirectorSell49,666$26.45$1,313,665.70  
1/8/2021Robert Lorne HopfnerDirectorSell40,612$26.58$1,079,466.96  
1/6/2021Robert Lorne HopfnerDirectorSell57,420$29.53$1,695,612.60  
12/21/2020Grant PickeringCEOSell15,000$28.88$433,200.00  
12/15/2020Group Holdings (Sbs) Advis TpgMajor ShareholderSell81,979$32.50$2,664,317.50  
10/8/2020Ra Capital Healthcare Fund LpMajor ShareholderSell266,258$50.78$13,520,581.24  
10/1/2020Ra Capital Healthcare Fund LpMajor ShareholderSell221,330$50.81$11,245,777.30
9/29/2020Ra Capital Management, L.P.Major ShareholderSell80,707$52.08$4,203,220.56  
6/16/2020Robert Lorne HopfnerDirectorBuy93,000$16.00$1,488,000.00
(Data available from 1/1/2013 forward)












PCVX Insider Trading Activity - Frequently Asked Questions

Who is on Vaxcyte's Insider Roster?

The list of insiders at Vaxcyte includes Andrew Guggenhime, Grant Pickering, Group Holdings (Sbs) Advis Tpg, Jane Wright-Mitchell, Jeff Fairman, Jim Wassil, Paul Sauer, Ra Capital Healthcare Fund Lp, Ra Capital Management, L.P., and Robert Lorne Hopfner. Learn more on insiders at PCVX.

What percentage of Vaxcyte stock is owned by insiders?

13.70% of Vaxcyte stock is owned by insiders. Learn more on PCVX's insider holdings.

Which Vaxcyte insiders have been selling company stock?

The following insiders have sold PCVX shares in the last 24 months: Andrew Guggenhime ($451,205.00), Grant Pickering ($5,390,193.03), Group Holdings (Sbs) Advis Tpg ($2,664,317.50), Jane Wright-Mitchell ($390,000.00), Jeff Fairman ($2,121,793.90), Jim Wassil ($425,244.00), Paul Sauer ($944,546.40), Ra Capital Healthcare Fund Lp ($24,766,358.54), Ra Capital Management, L.P. ($4,203,220.56), and Robert Lorne Hopfner ($12,248,934.06).

How much insider selling is happening at Vaxcyte?

Insiders have sold a total of 1,515,203 Vaxcyte shares in the last 24 months for a total of $53,605,812.99 sold.

This page (NASDAQ:PCVX) was last updated on 8/12/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.